When was Amgen founded?

Amgen was founded in 1980 and raised its 1st funding round 30 years after it was founded.

Where is Amgen located?

Amgen is headquartered in Thousand Oaks, United States. It is registered at Thousand Oaks, California.

How many employees does Amgen have?

As of Sep 30, 2026, the latest employee count at Amgen is 41670.

Is Amgen a funded company?

Amgen is a funded company, having raised an undisclosed amount across 2 funding rounds to date. The company's 1st funding round was a $***** Grant (prize money) round, raised on Jan 01, 2010.

When was the latest funding round of Amgen?

Amgen's latest funding was a $***** Post IPO round on Mar 12, 2012, with participation from 0 investor. Its primary sector is Diversified Pharmaceuticals. In United States, the Diversified Pharmaceuticals sector has seen $710M in funding in 2026 to date.

What is the annual revenue of Amgen?

Annual revenue of Amgen is more than $1B as on Dec 31, 2025

Where does Amgen rank among its competitors?

Amgen ranks 4th amongst 2090 active competitors, of which 114 are funded. It stands 5th in terms of total funding among its competitors. The most recent competitor to raise funding was AstraZeneca, which secured $6.05M in Jul, 2025.

Who are the top competitors of Amgen?

Amgen's top competitors include AbbVie, Merck and Gilead. Among them, AstraZeneca secured the most recent funding round in July, 2025.

Amgen - 2026 Company Profile, Team, Funding, Competitors & Financials

Company Details

Developer of pharmaceutical products for treating multiple diseases. It manufactures and market human therapeutics based on advances in cellular and molecular biology. It markets human therapeutic products in the areas of hematology, oncology, and inflammation. In 2022, the company recorded annual revenues of $26.32B and a net profit of $6.55B.

Website: www.amgen.com/
Social
Email ID: *****@amgen.com
Phone Number: +1 **********
Registered Address: Thousand Oaks, California

Key Metrics

Founded Year

1980

Location

Thousand Oaks, United States

Stage

Public

Latest Funding Round

Post IPO, Mar 12, 2012, $*****

Investors

Digital Pharma Lab & 12 more

Ranked

4^th among 2090 active competitors

Annual Revenue

$1B+ as on Dec 31, 2025

Employee Count

41,670 as on Sep 30, 2026

Investment & Acquisitions

Arboretum LifeSciences & 95 more

Similar Companies

AbbVie & 2119 more

Exit Details

Public

View Amgen's full profile

Amgen is associated with 10 legal entities given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
LAMGen s.r.o. CIN: 28331117 , Czech Republic, Active	Mar 10, 2009	-	-
AMGA Finance Solution s.r.o. CIN: 03516741 , Czech Republic, Active	Oct 24, 2014	-	-
Com8 s.r.o. CIN: 03506444 , Czech Republic, Active	Oct 22, 2014	-	-
Amgen Inc. CIN: 10208272 , United States, Active	Sep 11, 2022	-	-	-
AMGEN D.O.O. CIN: 18002446709 , Croatia, Active	Jul 15, 2013	€1M - €10M (As on Dec 31, 2024)	-
Amgen Inc CIN: 318154 , United States, Active	Oct 30, 1986	$1B+ (As on Dec 31, 2025)	-	-
AMGEN TECHNOLOGY PRIVATE LIMITED CIN: U62099MH2007FTC168485 , India, Active	Mar 08, 2007	₹100 - ₹500 Cr (As on Mar 31, 2025)	22 (As on Mar 31, 2024)
Amgen Inc. CIN: 953540776 , United States, Active	Dec 26, 999	-	14965 (As on Dec 31, 2024)	-
AMGEN MANUFACTURING, LIMITED CIN: 980210484 , United States, Active	Dec 26, 999	-	2589 (As on Dec 31, 2024)	-
Amgen CIN: - , Belgium, Active		-	-	-

Amgen got listed on Oct 01, 1984.

Click here to take a look at Amgen's IPO in detail

Amgen has raised funding over 2 rounds. Its first funding round was on Jan 01, 2010. Amgen has 13 institutional investors.

Here is the list of recent funding rounds of Amgen:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Mar 12, 2012	7386509	Post IPO	2584343	1931891	3810632	4901699
Jan 01, 2010	8461774	Grant (prize money)	3165581	5083551	9817742	Europa

Access funding benchmarks and valuations. Sign up today!

View details of Amgen's funding rounds and investors

The founders of Amgen is Kate Gavljak Mchem Ba. Robert Bradway is the CEO of Amgen.

Here are the details of Amgen's key team members:

Kate Gavljak Mchem Ba: Senior Product Manager, Head & Founder Patient Innovation Centre of Amgen.

View details of Amgen's Founder profiles and Board Members

Amgen's employee count trend

Amgen has 41,670 employees as of Sep 26. Here is Amgen's employee count trend over the years:

Uncover Amgen's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Amgen include AbbVie, Merck and Gilead. Here is the list of Top 10 competitors of Amgen, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	AbbVie 2012, Chicago (United States), Public	Research-based biopharmaceutical company	$14.7B	Berkshire Hathaway, Alcor Fund & 10 others	84/100
2nd	Merck 1891, Rahway (United States), Public	Manufacturer of pharmaceutical products	-	Bill & Melinda Gates Foundation, Berkshire Hathaway ... & 11 others	83/100
3rd	Gilead 1987, Foster City (United States), Acquired	Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others	-	BB Biotech, Jindal Ventures & 18 others	82/100
4th	Amgen 1980, Thousand Oaks (United States), Public	Developer of pharmaceutical products for treating multiple diseases	-	Digital Pharma Lab, Amgen Business Development ... & 11 others	80/100
5th	AstraZeneca 1999, Cambridge (United Kingdom), Public	Developer of pharmaceutical medicines for oncology and various chronic diseases	-	Digital Pharma Lab, Columbia Capital & 13 others	77/100
6th	Lilly 1876, Indianapolis (United States), Public	Developer of traditional pharmaceutical medicines	-	Alcor Fund, Digital Pharma Lab & 11 others	76/100
7th	Johnson & Johnson 1886, New Brunswick (United States), Public	Manufacturer and supplier of beauty care products, medical devices, and pharmaceutical products	-	Western Technology Investment, Alcor Fund ... & 17 others	76/100
8th	Novartis 1996, Basel (Switzerland), Acquired	R&D focused on manufacturing of drugs for multiple therapeutic areas	-	Digital Pharma Lab, Atlas Venture & 9 others	72/100
9th	Roivant Sciences 2014, New York City (United States), Public	Developer of therapeutics to treat neurology, oncology, rare, and endocrinology based diseases	$1.3B	SoftBank Vision Fund, NovaQuest Capital Management ... & 9 others	68/100
10th	Roche 1896, Basel (Switzerland), Public	Developer of pharmaceuticals and diagnostics kits	-	Gilde Healthcare, SoftBank Group & 12 others	71/100

Get insights and benchmarks for competitors of 2M+ companies! Sign up today!

Looking for more details on Amgen's competitors? Click here to see the top ones

Amgen has made 71 investments in companies including Arboretum LifeSciences and BigHat. Amgen has also acquired 25 companies including Dark Blue Therapeutics and Horizon Therapeutics.

Here is the list of investments & acquisitions:

Filter this list

Date of Investment/Acquisition	Type	Company Name	Founded Year	Location
Oct 07, 2026	Investments	Arboretum LifeSciences		Boston (United States)
Sep 24, 2026	Investments	BigHat	2019	San Carlos (United States)
May 26, 2026	Investments	Ember LifeSciences	2022	Westlake Village (United States)